Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vernal keratoconjunctivitis: pathogenesis and treatment.

Andrea Leonardi1

  • 1Department of Ophthalmology, University of Padua,Via Giustiniani 2, 35128 Padova, Italy. mdvol@tin.it

Progress in Retinal and Eye Research
|June 8, 2002
PubMed
Summary

Vernal keratoconjunctivitis (VKC) is an allergic eye disease primarily affecting young people. Research shows VKC involves Th2 lymphocytes, mast cells, and eosinophils, contributing to inflammation and treatment challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Evolution of Treatment Outcomes with Once-Daily Ciclosporin A 0.1% Cationic Emulsion in Patients with Dry Eye Disease and Severe Keratitis.

Ophthalmology and therapy·2026
Same author

Impact of migalastat therapy on corneal deposits in a female with Fabry disease: A case report.

Molecular genetics and metabolism reports·2026
Same author

Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways.

Investigative ophthalmology & visual science·2026
Same author

Ocular Microbiome in Dupilumab-Induced Ocular Surface Disease.

Allergy·2025
Same author

Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.

Allergy·2025
Same author

Recent Advances in Targeted Immunomodulatory Therapies for Chronic Ocular Surface Diseases.

Seminars in ophthalmology·2025

Area of Science:

  • Ophthalmology
  • Immunology
  • Allergy

Background:

  • Vernal keratoconjunctivitis (VKC) is a chronic allergic eye condition prevalent in children and young adults in warm climates.
  • Current understanding of VKC pathogenesis is limited, and anti-allergic treatments are frequently unsuccessful.
  • This study presents 11 years of research on the immunological characteristics of VKC.

Purpose of the Study:

  • To elucidate the immunological mechanisms underlying Vernal keratoconjunctivitis.
  • To identify key cellular and molecular players in VKC pathogenesis.
  • To provide insights for improved treatment strategies for VKC.

Main Methods:

  • Cytological, biohumoral, immunohistological, and molecular biological analyses were performed.
  • The study involved a cohort of 221 patients diagnosed with VKC.

Related Experiment Videos

  • Investigated cytokine, chemokine, growth factor, and enzyme expression in conjunctival tissues.

    • Main Results:

    • VKC is characterized as a Th2 lymphocyte-mediated disease.
    • Mast cells and eosinophils play significant roles in VKC's clinical presentation.
    • Over-expression of Th2 cytokines (IL-4, IL-5, IL-13), other mediators, and involvement of structural cells like epithelial cells and fibroblasts in inflammation and tissue remodeling (giant papillae formation) were observed.

    Conclusions:

    • VKC pathogenesis involves complex interactions between specific (IgE, Th2) and non-specific triggers.
    • Structural cells contribute to both inflammation and tissue remodeling, leading to giant papillae.
    • Understanding these immunological pathways is crucial for developing more effective therapeutic strategies for VKC.